
Sam ThilmanyDeutsche Sporthochschule Köln | DSHS · Institut für Biochemie
Sam Thilmany
Master of Science
PhD Candidate studying potential pathophysiological triggers of depression.
About
3
Publications
52
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
0
Citations
Citations since 2017
Introduction
I am investigating drug-induced changes in the neuronal proteome with regard to a possible link to the development of mental illness, particularly major depression. The goal is to uncover potential high-risk drugs and provide the impetus for regulatory action.
Additional affiliations
Education
October 2018 - January 2021
October 2014 - September 2018
Publications
Publications (3)
Depression is a common disorder with a worldwide prevalence of 3.8 %, according to the World Health Organization (WHO). Little is known about the risk factors for the development of depression. However, it seems clear that it is multifactorial and requires a complex interaction of social, psychological, and biological factors. A possible influence...
Bioactive peptides with a molecular mass between 2 and 10 kDa represent an important class of substances banned in elite sports, which has been recognized with an increasing number and variety of substances by anti-doping organizations. Also, the annually renewed list of prohibited substances of the World Anti-Doping Agency (WADA) explicitly mentio...
Marketing ist ein elementares Tool, um die gesellschaftliche Präsenz von Projekten zu stärken. In diesem Kapitel sollen die Probleme einer Marketingstrategie anhand des realen Beispiels QR-Help aufgezeigt werden. Bei QR-Help handelt es sich um eine elektronische Notfall-Gesundheitsakte, bei der jegliche Informationen vom Patienten frei angegeben un...
Network
Projects
Projects (2)
Bioactive peptides with a molecular mass between 2 and 10 kDa
represent an important class of substances banned in elite sports. Our aim is to develop a co-extraction method for the analysis of several different peptides, such as inulins, growth hormone-releasing hormones, insulin-like growth factors, and mechano growth factors.
I am investigating drug-induced changes in the neuronal proteome with regard to a possible link to the development of mental illness, particularly major depression. The goal is to uncover potential high-risk drugs and provide the impetus for regulatory action.